Study of EPN-701 for the Treatment of Calciphylaxis
Study of EPN-701 for the Treatment of Calciphylaxis
Not yet recruiting · NCT07583745 · Registry updated 2026-09-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of EPN-701 for the Treatment of Calciphylaxis | Nutritional and Metabolic Diseases, calcinosis, calciphylaxis, calcium metabolic disease, metabolic disease | Not yet recruiting | Phase 2 | 2026-09-14 | NCT07583745 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Epizon Pharma, Inc. | 1 |
| Sagar U. Nigwekar, MD, MMSc | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renal Associates | Boston | United States | 1 |